On the 4th, HK Inno.N announced that it had officially released its novel gastroesophageal reflux disease (GERD) treatment K-CAB in Singapore.

HK Inno.N held a symposium to celebrate K-CAB’s launch at the Conrad Centennial Singapore Hotel on August 31st.

K-CAB was approved in February in Singapore under the same brand name, K-CAB. HK Inno.N will export the finished product to its local partner, United Italian Trading Corporation (UITC), which will be in charge of local sales and marketing of K-CAB in Singapore.

The symposium, which was held for gastroenterologists in Singapore, was hosted by UITC. At the symposium, Professor Prakash Gyawali (Department of Gastroe